Get started
Author

Louis J. Nykamp

Observed names: Louis Nykamp, Speaker: Louis Nykamp
OpenAlex ID: A5050202437
Safety and utility of acute electroconvulsive therapy for agitation and aggression in dementia
2014 · Deepa Acharya, David G. Harper, et al. · International Journal of Geriatric Psychiatry · 82
Electroconvulsive Therapy Practice Changes in Older Individuals Due to COVID-19: Expert Consensus Statement
2020 · Maria I. Lapid, Stephen Seiner, et al. · American Journal of Geriatric Psychiatry · 32
PDF
Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial
2024 · Balwinder Singh, Sagar V. Parikh, et al. · Psychiatry Research · 20
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression
2023 · Sagar V. Parikh, Jennifer L. Vande Voort, et al. · Journal of Affective Disorders · 14
Electroconvulsive therapy for the acute management of severe agitation in dementia (ECT-AD): A modified study protocol
2024 · Maria I. Lapid, Julia Merrill, et al. · PLoS ONE · 8
Electroconvulsive Therapy for the Treatment of Acute Agitation and Aggression in Alzheimer's Dementia (ect-ad)
2019 · Brent P. Forester, Emily Mellen, et al. · American Journal of Geriatric Psychiatry · 7
Evidence-based practice guideline for the treatment of adult patients with depressive disorders. Part I: Psychiatric management
2018 · Vitaliy Voytenko, Louis Nykamp, et al. · Psychiatria i Psychologia Kliniczna · 5
Treatment Parameters and Rationale for the Use of Electroconvulsive Therapy for the Management of Treatment-refractory Agitation in Alzheimer's Disease
2020 · Adriana P. Hermida, Georgios Petrides, et al. · American Journal of Geriatric Psychiatry · 4
High Baseline Plasma Anthranilic Acid Predicts Remission Upon Acute-Series Ketamine Infusion for Treatment-Resistant Depression
2025 · Stephen A. Murata, Zachary B. Madaj, et al. · Biological Psychiatry Global Open Science · 3
Evidence for Electroconvulsive Therapy (ect) in the Treatment of Intractable Behavioral Symptoms of Dementia (bpsd): a Systematic Review
2020 · Brent Forester, Aniqa Rahman, et al. · American Journal of Geriatric Psychiatry · 2
Depression Remission and Response Rates and Anxiety Response as a Predictor of Depression Response in a Community Electroconvulsive Therapy Clinic
2025 · Sara B. VanBronkhorst, Joseph J. Keller, et al. · The Primary Care Companion For CNS Disorders · 1
Refining the ECT-Dementia Trial Protocol in Response to Recruitment Challenges
2024 · Valeriya Tsygankova, Maria Lapid, et al. · American Journal of Geriatric Psychiatry · 1
A Novel Approach to Monitoring Cognitive Adverse Events for Interventional Studies Involving Advanced Dementia Patients: Insights From the Electroconvulsive Therapy for Agitation in Dementia Study
2023 · Soohyun Park, Brent P. Forester, et al. · Journal of Geriatric Psychiatry and Neurology · 1
Depression Remission and Response Rates and Anxiety Response as a Predictor of Depression Response in a Community ECT Clinic
2021 · Sara B. VanBronkhorst, Evonne M. Edwards, et al. · medRxiv · 1
PDF
Evidence-based practice guideline for the treatment of adult patients with depressive disorders. Part II: Psychotherapy
2018 · Vitaliy Voytenko, Krista Anderson, et al. · Psychiatria i Psychologia Kliniczna · 1
A Structured Consent Framework for Research of Electroconvulsive Therapy in Advanced Dementia
2026 · Andrew L. Holzman, Brent P. Forester, et al. · Journal of Ect
198. Plasma Lactate as a Metabolic Predictor of Ketamine Response in Treatment-Resistant Depression
2026 · Giselli Scaini, Camilla Teixeira Pinheiro Gusmao, et al. · Biological Psychiatry
Innovative Neuromodulatory Interventions: Advancing Treatments for Older Adults with Mood and Neurocognitive Disorders through ECT, TMS, and tDCS.
2025 · Chair: Brent Forester, Speaker: George Petrides, et al. · American Journal of Geriatric Psychiatry
The ECT-AD trial for severe treatment-refractory agitation and aggression in advanced dementia: Scientific rationale and study design
2025 · Georgios Petrides, Maria Lapid, et al. · Brain stimulation
PDF
ECT‐AD: Baseline Demographics of a Novel Therapeutic Intervention for Severe Agitation and Aggression in Dementia
2024 · Brent P. Forester, Julia G. Merrill, et al. · Alzheimer s & Dementia
PDF
Advancing Research: The ECT-AD Study and Recent Updates
2024 · Maria Lapid, Brent Forester, et al. · American Journal of Geriatric Psychiatry
ECT-AD Trial: Rationale for ECT lead placement and dosing in the treatment of refractory agitation and aggression in dementia
2023 · Valeriya Tsygankova, Cristina Pritchett, et al. · American Journal of Geriatric Psychiatry
Identifying delirium in advanced dementia in the ECT‐AD clinical trial
2022 · Maria I. Lapid, Brent P. Forester, et al. · Alzheimer s & Dementia
PDF
A new cognitive safety monitoring plan for interventional studies involving patients with advanced dementia: Insights from the ECT-AD Study
2022 · Soohyun Park, Regan Patrick, et al. · American Journal of Geriatric Psychiatry
213 - ECT-AD: Ethics and informed consent issues
2021 · Louis Nykamp, Brent P. Forester, et al. · International Psychogeriatrics
PDF
Works count: 28
Citation count: 182
H-index: 6
I10-index: 4
Year
Topic
Type